Problems with analyses and interpretation of data in “use of the KDQOL-36™ for assessment of health-related quality of life among dialysis patients in the United States”

por Hays, Ron D., Peipert, John D., Kallich, Joel D.
Publicado 2019

Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis

por Curtis, Jeffrey R., Xie, Fenglong, Kay, Jonathan, Kallich, Joel D
Publicado 2019

Modified Capitation and Treatment Incentives for End Stage Renal Disease

por Farley, Donna O., Carter, Grace M., Kallich, Joel D., Lucas, Thomas W., Spritzer, Karen L
Publicado 1996

Using Certification to Promote Uptake of Real-World Evidence by Payers

por Segal, Jodi B., Kallich, Joel D., Oppenheim, Emma R., Garrison, Louis P., Iqbal, Sheikh Usman, Kessler, Marla, Caleb Alexander, G.
Publicado 2016